Lennert's lymphoma: a variant of cytotoxic T-cell lymphoma? 2000

Y Yamashita, and S Nakamura, and Y Kagami, and Y Hasegawa, and H Kojima, and T Nagasawa, and N Mori
First Department of Pathology, Nagoya University School of Medicine, Japan. k46581a@nucc.cc.nagoya-u.ac.jp

We studied 10 cases of Lennert's lymphoma (lymphoepithelioid lymphoma) to evaluate the cellular origin of the neoplastic cells. There were six men and four women, aged 38 to 75 years (median, 56 yrs; mean, 59 yrs). The lymphoma cells tended to remain confined to lymph nodes, and extranodal involvement was rare. The mean overall survival was 42.2 months, which is relatively good compared with other peripheral T-cell lymphomas. Morphologically, the lymph node was occupied by small to large clusters of epithelioid cells interspersed with medium to large atypical lymphoid cells. In seven cases, large atypical lymphoid cells resembling Hodgkin's or Reed-Sternberg cells were observed. The phenotypes of these neoplastic cells were CD3+ CD4- CD8+ in five cases, CD3+ CD4+ CD8- in four cases, and CD3+ CD4- CD8- in one case. TIA-1 was positive by immunohistochemical staining in seven cases, whereas four cases were positive for granzyme B. Clonal rearrangement of the T-cell receptor gene was confirmed in all cases by either Southern blot hybridization or a polymerase chain reaction-based denature gradient gel electrophoresis method. Epstein-Barr virus was negative by in situ hybridization in all but one case. Lennert's lymphoma was formerly known as a CD4+ helper T-cell neoplasm. Our results suggest that, at least in some cases, the neoplastic cells are of cytotoxic T-cell origin.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA

Related Publications

Y Yamashita, and S Nakamura, and Y Kagami, and Y Hasegawa, and H Kojima, and T Nagasawa, and N Mori
June 1978, American journal of clinical pathology,
Y Yamashita, and S Nakamura, and Y Kagami, and Y Hasegawa, and H Kojima, and T Nagasawa, and N Mori
November 1986, British journal of haematology,
Y Yamashita, and S Nakamura, and Y Kagami, and Y Hasegawa, and H Kojima, and T Nagasawa, and N Mori
March 2005, Clinical and experimental dermatology,
Y Yamashita, and S Nakamura, and Y Kagami, and Y Hasegawa, and H Kojima, and T Nagasawa, and N Mori
May 2005, Leukemia & lymphoma,
Y Yamashita, and S Nakamura, and Y Kagami, and Y Hasegawa, and H Kojima, and T Nagasawa, and N Mori
October 1987, Nihon juigaku zasshi. The Japanese journal of veterinary science,
Y Yamashita, and S Nakamura, and Y Kagami, and Y Hasegawa, and H Kojima, and T Nagasawa, and N Mori
October 1978, La Nouvelle presse medicale,
Y Yamashita, and S Nakamura, and Y Kagami, and Y Hasegawa, and H Kojima, and T Nagasawa, and N Mori
November 2015, Acta dermato-venereologica,
Y Yamashita, and S Nakamura, and Y Kagami, and Y Hasegawa, and H Kojima, and T Nagasawa, and N Mori
October 2004, Virchows Archiv : an international journal of pathology,
Y Yamashita, and S Nakamura, and Y Kagami, and Y Hasegawa, and H Kojima, and T Nagasawa, and N Mori
June 2012, International journal of laboratory hematology,
Y Yamashita, and S Nakamura, and Y Kagami, and Y Hasegawa, and H Kojima, and T Nagasawa, and N Mori
February 1989, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
Copied contents to your clipboard!